Warning letter analysis shows FDA has target on CBD, not hemp
An analysis of recent warning letters underscores the notion that FDA is focused its enforcement efforts on CBD, and is not targeting hemp extracts per se.
News, Analysis & Insights on Nutrition, Supplements, and Health
An analysis of recent warning letters underscores the notion that FDA is focused its enforcement efforts on CBD, and is not targeting hemp extracts per se.
Despite all the buzz around CBD and the near steady stream of product launches across food and beverage categories featuring the ingredient, the majority of Americans have not heard of the ingredient, never used it or have no interest in it, according to...
WATCH NOW
With the deadline for applications to the NutraIngredients Awards fast approaching, it's vital that you get your applications in soon. But which award should you apply for, and what are the key criteria for the categories? Our helpful video will guide...
A probiotic strain containing a new type of plasmid could be a ‘promising’ new weapon in the fight against antibiotic bacteria, say the UK Researchers behind the project.
AkzoNobel’s iron compound for use in supplements and fortifying baby foods poses no danger to consumers, say regulators, who rule exposure to nanoparticles possibly in the product as ‘unlikely.’